Discover
Stocks
Consumer Goods
BPMC
BPMC
Blueprint Medicines Corp
52.07
0.14
(
0.27%
)
Market Open
Delayed Prices By NASDAQ,
in USD
Trade
Buy
BPMC
Blueprint Medicines Corp
Overview
Chart
Analysis
News
Stats
Trade
Buy
FINANCIAL SUMMARY
For the fiscal year ended 31/12/2022: Blueprint Medicines Corp's revenues increased by 13.30% and amounted to 204.04M. Net income increased by 13.44% to -557.52M. Net assets increased by 9.54% to 1.33B and EPS increased from -11.01 to -9.35.
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Gross Margin
Net Profit Margin
Operating Margin
Return On Investment